7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Valvular Atrial Fibrillation
Valvular Atrial Fibrillation (VAF) is a distinct category of atrial fibrillation that manifests in individuals with significant heart valve disorders. The abnormal electrical signals within the atria, or upper chambers of the heart, lead to irregular and often accelerated heartbeats. The link between VAF and valvular heart diseases, such as mitral stenosis or the presence of a mechanical heart valve, underscores the complexity of this condition. The management of VAF requires a nuanced approach, taking into account both the atrial fibrillation and the underlying valvular pathology. Healthcare professionals navigate treatment strategies based on factors like the severity of the valve disease, the overall health status of the patient, and individual considerations unique to each case. Striking a balance between addressing atrial fibrillation and managing valvular issues is crucial for effective care.
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Arthur J Siegel
Massachusetts General Hospital, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya